Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder.
Foa, Edna B
Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder. [electronic resource] - The Journal of clinical psychiatry Apr 2015 - 440-6 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
1555-2101
10.4088/JCP.14m09044 doi
Adolescent
Adult
Aged
Combined Modality Therapy
Female
Follow-Up Studies
Humans
Implosive Therapy
Male
Middle Aged
Obsessive-Compulsive Disorder--diagnosis
Risperidone--adverse effects
Selective Serotonin Reuptake Inhibitors--adverse effects
United States
Young Adult
Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder. [electronic resource] - The Journal of clinical psychiatry Apr 2015 - 440-6 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
1555-2101
10.4088/JCP.14m09044 doi
Adolescent
Adult
Aged
Combined Modality Therapy
Female
Follow-Up Studies
Humans
Implosive Therapy
Male
Middle Aged
Obsessive-Compulsive Disorder--diagnosis
Risperidone--adverse effects
Selective Serotonin Reuptake Inhibitors--adverse effects
United States
Young Adult